Randomized Study of the pdSTIM™ System in Failure to Wean Mechanically Ventilated Patients (ReInvigorate)
Randomized Study of the pdSTIM™ System (Phrenic Nerve to Diaphragm STIMulation) in Failure to Wean Mechanically Ventilated Patients
Sponsor: Stimdia Medical Inc.
Suspended
Enrollment was temporarily paused to allow for protocol evaluation and planned modifications.
A NA clinical study on Mechanical Ventilation Weaning and Neuromodulation, this trial is suspended. The trial is conducted by Stimdia Medical Inc. and has accumulated 15 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)The pdSTIM Pivotal Study (ReInvigorate Study) is a prospective, multicenter, randomized, controlled clinical study to evaluate the safety and efficacy of the pdSTIM System to facilitate weaning from mechanical ventilation through phrenic nerve stimulation. Potential subjects who are on mechanical ventilation for ≥ 96 hours (4 days) and have failed at least one weaning attempt will be considered for the study.
Those enrolled will be randomized in a 1:1 manner between a Treatment group that is standard of care with the pdSTIM System and a Control group that is standard of care only. For the Treatment group, stimulation therapy with pdSTIM will occur daily until the subject is successfully removed from mechanical ventilation or the 30-Day follow-up visit, whichever is sooner. All randomized subjects will be followed to 60 (± 7) days post randomization. Total subject participation will be no longer than 67 days.
The pdSTIM Pivotal Study (ReInvigorate Study) is a prospective, multicenter, randomized, controlled clinical study to evaluate the safety and efficacy of the pdSTIM System to facilitate weaning from mechanical ventilation through phrenic nerve stimulation. Potential subjects who are on mechanical ventilation for ≥ 96 hours (4 days) and have failed at least one weaning attempt will be considered for the study.
Those enrolled will be randomized in a 1:1 manner between a Treatment group that is standard of care with the pdSTIM System and a Control group that is standard of care only. For the Treatment group, stimulation therapy with pdSTIM will occur daily until the subject is successfully removed from mechanical ventilation or the 30-Day follow-up visit, whichever is sooner. All randomized subjects will be followed to 60 (± 7) days post randomization. Total subject participation will be no longer than 67 days.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Suspended NA
-
Feb 2026 — Present [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jan 2026 — Present [monthly]
Recruiting NA
-
Oct 2024 — Feb 2026 [monthly]
Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
▶ Show 10 earlier versions
-
Aug 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2024 — Aug 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Apr 2024 — Jun 2024 [monthly]
Recruiting NA
-
Mar 2024 — Apr 2024 [monthly]
Recruiting NA
-
Feb 2024 — Mar 2024 [monthly]
Recruiting NA
-
Jan 2024 — Feb 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jan 2024 [monthly]
Recruiting NA
-
Nov 2023 — Dec 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Stimdia Medical Inc.
For direct contact, visit the study record on ClinicalTrials.gov .